--- title: "VITRUVIAS THERAPEUTICS INC Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search VITRUVIAS THERAPEUTICS INC recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/vitruvias-therapeutics-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # VITRUVIAS THERAPEUTICS INC recall records **1** reported ongoing 2 records in this archive. Latest source date Aug 24, 2026. 1 published notices do not supply a closure status. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Aug 24, 2026 FDA company announcement ### [Vitruvias Therapeutics: Thyroid Tablets, USP 30 mg](https://isitonrecall.com/recall/fdapress-19092c9309b8774e-vitruvias-therapeutics-thyroid-tablets-usp-30-mg/) Potential for the Product to be Superpotent Not supplied Published notice; closure not supplied Distribution: Not supplied [Official source for Vitruvias Therapeutics: Thyroid Tablets, USP 30 mg](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vitruvias-therapeutics-inc-issues-nationwide-recall-one-lot-thyroid-tablets-usp-30-mg-due-potential) Aug 21, 2026 FDA drug enforcement ### [Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics...](https://isitonrecall.com/recall/fda-drug-d-0866-2026-thyroid-tablets-usp-1-2-grain-30-mg-each-tablet-contains-levothyroxine-t4-19-mcg-liothyronine-t3-4-5/) Superpotent Drug Class I Reported ongoing Distribution: US Nationwide. [Official source for Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyr...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0866-2026%22) ## Reasons in these listed records - Potential for the Product to be Superpotent - Superpotent Drug These examples come from this result page and are not a ranking of every recall reason. ## Checking VITRUVIAS THERAPEUTICS INC ### Is there a recall on vitruvias therapeutics inc right now? This archive contains 2 records, including 1 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search VITRUVIAS THERAPEUTICS INC](https://isitonrecall.com/check/?q=VITRUVIAS%20THERAPEUTICS%20INC) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)